Acadian Asset Management LLC Ardelyx, Inc. Transaction History

Acadian Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 08, 2019	SELL	$2.49 - $3.73 $250,404 - $375,103	-100,564 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$1.88 - $3.35 $85,126 - $151,688	45,280 Added 81.9%	100,564 $282,000
Q4 2018 Feb 07, 2019	BUY	$1.66 - $4.16 $59,730 - $149,685	35,982 Added 186.42%	55,284 $99,000
Q3 2018 Oct 30, 2018	BUY	$3.75 - $4.65 $21,881 - $27,132	5,835 Added 43.33%	19,302 $84,000
Q2 2018 Jul 24, 2018	BUY	$3.7 - $5.8 $49,827 - $78,108	13,467 New	13,467 $50,000
Q1 2018 Apr 12, 2018	SELL	$5.05 - $7.9 $38,703 - $60,545	-7,664 Closed	0 $0
Q4 2017 Jan 18, 2018	BUY	$4.85 - $7.8 $37,170 - $59,779	7,664	7,664 $51,000

209

144M

1.01M

1.43M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $1.05B
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.